Journal article

Elevated labile Cu is associated with oxidative pathology in Alzheimer disease

Simon A James, Irene Volitakis, Paul A Adlard, James A Duce, Colin L Masters, Robert A Cherny, Ashley I Bush

Free Radical Biology and Medicine | ELSEVIER SCIENCE INC | Published : 2012


Funding Acknowledgements

We thank Fairlie Hinton and Dr. Catriona McLean for the provision of neuropathologically characterized human brain samples (through the NNTRC) and Monica Lind and Dr. Alan Rembach for useful discussions and assistance with laboratory studies. This work was supported by funds from the Australian Research Council and the National Health and Medical Research Council, Operational Infrastructure Support from the Victoria state government, the Alzheimer's Association, and the CSIRO OCE Postdoctoral Fellowship Program. A.I.B. is a paid consultant to Adeona Pharmaceuticals, a shareholder of Brighton Biotech, and has received speaker payments from Amgen. C.L.M., R.A.C., and A.I.B. are shareholders in and paid consultants to Prana Biotechnology Ltd.